Markets
Moderna Cancer Vaccine Breakthrough Revives Hopes for Biotech Turnaround
Moderna's landmark cancer vaccine data has sent shockwaves through biotech markets, reigniting a sector that has spent much of 2026 searching for a catalyst. Traders are now weighing whether this is a genuine inflection point or another head-fake in a notoriously volatile space.